Human T-cell lymphotropic virus type 1 (HTLV-1) was the first pathogenic human retrovirus to be discovered. It was isolated in 1979 from the peripheral blood lymphocytes of a patient with adult T-cell leukemia/lymphoma (ATLL) (1). Following years of research to find a retroviral agent involved in ATLL, Yoshida and Yamamato isolated a retrovirus from an ATLL patient in 1986 that they named adult T-cell leukemia virus. Soon, the similarities between HTLV-1 and adult T-cell leukemia virus were confirmed, and the name HTLV-1 was chosen. Shortly thereafter, the closely related virus HTLV-2 was isolated from the splenic cells of an individual with hairy cell T-cell leukemia (2).

Representative examples of HTLV-1-positive and HTLV-2-positive WB patterns. WB patterns can also demonstrate indeterminate reactivity, and two examples of this are shown here (IND-1 and -2). This can complicate the interpretation of results.

10.1128/9781555818722/8722ch70fig1_thmb.gif

10.1128/9781555818722/8722ch70fig1.gif

FIGURE 1

Representative examples of HTLV-1-positive and HTLV-2-positive WB patterns. WB patterns can also demonstrate indeterminate reactivity, and two examples of this are shown here (IND-1 and -2). This can complicate the interpretation of results.

19.World Health Organization Regional Office for the Western Pacific. 1989. Scientific Group on HTLV-I Infections and Associated Diseases: Report. World Health Organization Regional Office for the Western Pacific, Manila Philippines.

29.AndradeRG,RibeiroMA,Namen-LopesMS,SilvaSM,BasquesFV,RibasJG,Carneiro-ProiettiAB,MartinsML.2010. Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors. Rev Soc Bras Med Trop43:111–115.[PubMed].[CrossRef]

36.YanagiharaR,GarrutoRM,MillerMA,Leon-MonzonM,LiberskiPP,GajdusekDC,JenkinsCL,SandersRC,AlpersMP.1990. Isolation of HTLV-I from members of a remote tribe in New Guinea. N Engl J Med323:993–994.[CrossRef].[PubMed]

37.DelaporteE,MonplaisirN,LouwagieJ,PeetersM,Martin-PrévelY,LouisJP,TrebucqA,BedjabagaL,OssariS,HonoréC.1991. Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int J Cancer49:373–376.[PubMed].[CrossRef]

38.GarinB,GosselinS,de ThéG,GessainA.1994. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate Western blot pattern. J Med Virol44:104–109.[PubMed].[CrossRef]

43.BuschMP,SwitzerWM,MurphyEL,ThomsonR,HeneineW.2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion40:443–449.[PubMed].[CrossRef]

44.RobertsBD,FoungSK,LipkaJJ,KaplanJE,HadlockKG,ReyesGR,ChanL,HeneineW,KhabbazRF.1993. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II. J Clin Microbiol31:260–264.[PubMed]

48.DeferC,CosteJ,DescampsF,VoisinS,LemaireJM,ManiezM,CouroucéAMRetrovirus Study Group of the French Society of Blood Transfusion. 1995. Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Transfusion35:596–600.[PubMed].[CrossRef]

53.MatsuzakiT,NakagawaM,NagaiM,UsukuK,HiguchiI,ArimuraK,KubotaH,IzumoS,AkibaS,OsameM.2001. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol7:228–234.[CrossRef].[PubMed]